세계의 안구건조증 치료 장치 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 분석 및 예측(2025-2034년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for dry eye disease treatment devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global dry eye disease treatment devices market from 2025 to 2032.

Key Insights:

• Dry Eye Disease Treatment Devices Market Size (2025E): USD 302.3 Million
• Projected Market Value (2032F): USD 483.5 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 6.9%

Dry Eye Disease Treatment Devices Market - Report Scope:

Dry eye disease treatment devices play a crucial role in managing and alleviating symptoms of dry eye syndrome, which affects millions of people worldwide. These devices include thermal pulsation systems, intense pulsed light (IPL) devices, and meibomian gland expression tools that improve tear film stability and reduce ocular discomfort. The market serves ophthalmology clinics, hospitals, ambulatory surgical centers, and homecare settings, offering solutions that address the underlying causes of dry eye disease rather than only providing symptomatic relief. Market growth is driven by the rising prevalence of dry eye conditions, an aging population, and technological advancements that enhance treatment effectiveness and patient comfort.

Market Growth Drivers:

The global dry eye disease treatment devices market is propelled by several key factors, including increasing awareness of the impact of dry eye disease on vision-related quality of life and growing demand for non-pharmacological treatment alternatives. The rising incidence of dry eye syndrome due to prolonged screen time, environmental factors, and higher rates of refractive surgeries further fuels market expansion. Technological innovations such as automated thermal pulsation devices, portable IPL systems, and devices integrated with real-time diagnostic capabilities contribute to improved treatment outcomes and drive adoption across diverse care settings. Additionally, favorable reimbursement frameworks and supportive clinical guidelines are expanding patient access to advanced dry eye therapies.

Market Restraints:

Despite promising growth prospects, the dry eye disease treatment devices market faces challenges related to high equipment costs, limited reimbursement coverage in certain regions, and concerns about the efficacy and safety of newer device-based interventions. Regulatory complexities governing the approval and marketing of ophthalmic devices increase compliance burdens and lengthen product development timelines. Moreover, a lack of standardized treatment protocols and variability in physician training and patient education can impact optimal device utilization and treatment adherence. Overcoming these barriers will require collaboration among device manufacturers, healthcare professionals, and policymakers to streamline regulations, promote evidence-based practices, and improve affordability.

Market Opportunities:

The dry eye disease treatment devices market presents significant opportunities driven by demographic trends, rising patient awareness, and the integration of digital health technologies. Remote monitoring tools and teleophthalmology platforms enable more frequent patient engagement and personalized treatment plans, supporting improved adherence and outcomes. Expanding applications of dry eye treatment devices beyond traditional ophthalmology, including post-LASIK care and management of ocular rosacea, further broaden market potential. Investment in research and development, strategic collaborations, and the introduction of cost-effective, user-friendly solutions will be essential to capitalize on emerging opportunities and strengthen market position in this dynamic therapeutic area.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the dry eye disease treatment devices market globally?
• Which device types and care settings are driving adoption across different regions?
• How are technological advancements reshaping the competitive landscape of the dry eye disease treatment devices market?
• Who are the key players contributing to market development, and what strategies are they employing to maintain competitiveness?
• What are the emerging trends and future prospects in the global dry eye disease treatment devices market?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop advanced treatment devices, such as portable thermal pulsation systems and multifunctional IPL platforms, tailored to various patient needs and clinical workflows. Collaborations with ophthalmology practices, distributors, and regulatory authorities support broader market access and faster technology adoption. Additionally, emphasis on clinician training, patient education, and real-world evidence generation strengthens market growth and reinforces trust in device-based dry eye therapies.

Key Companies Profiled:

• Johnson & Johnson Services, Inc.
• Sight Sciences
• Alcon
• Mibo Medical Group
• Holbar Medical Products
• NuSight Medical
• BlephEx(R), LLC
• Lumenis
• BioTissue
• Boston Foundation for Sight
• EyePrint Prosthetics, LLC
• Olympic Ophthalmics Inc.
• Quantel Medical (Lumibird Medical)
• ESW Vision
• Nordic Pharma, Inc.
• Katena Products, Inc (Corza Ophthalmology)
• Reichert
• Eyedetec Medical, Inc.
• Meidixin (Tianjin) Co. Ltd
• Sunways India Pvt Ltd.
• Espansione Group
• Essilor Ltd
• SEODONG MEDICAL
• InMode Australia
• Novoxel

Dry Eye Disease Treatment Devices Market Research Segmentation:

The dry eye disease treatment devices market encompasses a diverse range of products, applications, end-user segments, and regional markets, supporting the management of multiple forms of dry eye disease.

By Product

• Intense Pulsed Light Therapy Devices
• Thermal Pulsation Therapy Devices
• Neurostimulation Devices
• Punctual Occlusion Devices
• Others

By Application

• Chronic Dry Eye
• Acute Dry Eye

By End-user

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Dry Eye Disease Treatment Devices Market Outlook

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 5.3. Global Dry Eye Disease Treatment Devices Market Outlook: Product
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
  • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 5.3.3.1. Intense Pulsed Light Therapy Devices
    • 5.3.3.2. Thermal Pulsation Therapy Devices
    • 5.3.3.3. Neurostimulation Devices
    • 5.3.3.4. Punctual Occlusion Devices
    • 5.3.3.5. Others
  • 5.3.4. Market Attractiveness Analysis: Product
• 5.4. Global Dry Eye Disease Treatment Devices Market Outlook: Application
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
  • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 5.4.3.1. Chronic Dry Eye
    • 5.4.3.2. Acute Dry Eye
  • 5.4.4. Market Attractiveness Analysis: Application
• 5.5. Global Dry Eye Disease Treatment Devices Market Outlook: End User
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 5.5.3.1. Hospitals
    • 5.5.3.2. Ophthalmic Clinics
    • 5.5.3.3. Ambulatory Surgical Centers
    • 5.5.3.4. Homecare Settings
    • 5.5.3.5. Others
  • 5.5.4. Market Attractiveness Analysis: End User

6. Global Dry Eye Disease Treatment Devices Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Dry Eye Disease Treatment Devices Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By End User
• 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1. Intense Pulsed Light Therapy Devices
  • 7.4.2. Thermal Pulsation Therapy Devices
  • 7.4.3. Neurostimulation Devices
  • 7.4.4. Punctual Occlusion Devices
  • 7.4.5. Others
• 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.5.1. Chronic Dry Eye
  • 7.5.2. Acute Dry Eye
• 7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1. Hospitals
  • 7.6.2. Ophthalmic Clinics
  • 7.6.3. Ambulatory Surgical Centers
  • 7.6.4. Homecare Settings
  • 7.6.5. Others
• 7.7. Market Attractiveness Analysis

8. Europe Dry Eye Disease Treatment Devices Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End User
• 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1. Intense Pulsed Light Therapy Devices
  • 8.4.2. Thermal Pulsation Therapy Devices
  • 8.4.3. Neurostimulation Devices
  • 8.4.4. Punctual Occlusion Devices
  • 8.4.5. Others
• 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.5.1. Chronic Dry Eye
  • 8.5.2. Acute Dry Eye
• 8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1. Hospitals
  • 8.6.2. Ophthalmic Clinics
  • 8.6.3. Ambulatory Surgical Centers
  • 8.6.4. Homecare Settings
  • 8.6.5. Others
• 8.7. Market Attractiveness Analysis

9. East Asia Dry Eye Disease Treatment Devices Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End User
• 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1. Intense Pulsed Light Therapy Devices
  • 9.4.2. Thermal Pulsation Therapy Devices
  • 9.4.3. Neurostimulation Devices
  • 9.4.4. Punctual Occlusion Devices
  • 9.4.5. Others
• 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.5.1. Chronic Dry Eye
  • 9.5.2. Acute Dry Eye
• 9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1. Hospitals
  • 9.6.2. Ophthalmic Clinics
  • 9.6.3. Ambulatory Surgical Centers
  • 9.6.4. Homecare Settings
  • 9.6.5. Others
• 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Dry Eye Disease Treatment Devices Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End User
• 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1. Intense Pulsed Light Therapy Devices
  • 10.4.2. Thermal Pulsation Therapy Devices
  • 10.4.3. Neurostimulation Devices
  • 10.4.4. Punctual Occlusion Devices
  • 10.4.5. Others
• 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.5.1. Chronic Dry Eye
  • 10.5.2. Acute Dry Eye
• 10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Hospitals
  • 10.6.2. Ophthalmic Clinics
  • 10.6.3. Ambulatory Surgical Centers
  • 10.6.4. Homecare Settings
  • 10.6.5. Others
• 10.7. Market Attractiveness Analysis

11. Latin America Dry Eye Disease Treatment Devices Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By End User
• 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1. Intense Pulsed Light Therapy Devices
  • 11.4.2. Thermal Pulsation Therapy Devices
  • 11.4.3. Neurostimulation Devices
  • 11.4.4. Punctual Occlusion Devices
  • 11.4.5. Others
• 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.5.1. Chronic Dry Eye
  • 11.5.2. Acute Dry Eye
• 11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Hospitals
  • 11.6.2. Ophthalmic Clinics
  • 11.6.3. Ambulatory Surgical Centers
  • 11.6.4. Homecare Settings
  • 11.6.5. Others
• 11.7. Market Attractiveness Analysis

12. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Product
  • 12.2.3. By Application
  • 12.2.4. By End User
• 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 12.4.1. Intense Pulsed Light Therapy Devices
  • 12.4.2. Thermal Pulsation Therapy Devices
  • 12.4.3. Neurostimulation Devices
  • 12.4.4. Punctual Occlusion Devices
  • 12.4.5. Others
• 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 12.5.1. Chronic Dry Eye
  • 12.5.2. Acute Dry Eye
• 12.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 12.6.1. Hospitals
  • 12.6.2. Ophthalmic Clinics
  • 12.6.3. Ambulatory Surgical Centers
  • 12.6.4. Homecare Settings
  • 12.6.5. Others
• 12.7. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Johnson & Johnson Services, Inc.
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Product
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Sight Sciences
  • 13.3.3. Alcon
  • 13.3.4. Mibo Medical Group
  • 13.3.5. Holbar Medical Products
  • 13.3.6. NuSight Medical
  • 13.3.7. BlephEx(R), LLC
  • 13.3.8. Lumenis
  • 13.3.9. BioTissue
  • 13.3.10. Boston Foundation for Sight
  • 13.3.11. EyePrint Prosthetics, LLC
  • 13.3.12. Olympic Ophthalmics Inc.
  • 13.3.13. Quantel Medical (Lumibird Medical)
  • 13.3.14. ESW Vision
  • 13.3.15. Nordic Pharma, Inc.
  • 13.3.16. Katena Products, Inc (Corza Ophthalmology)
  • 13.3.17. Reichert
  • 13.3.18. Eyedetec Medical, Inc.
  • 13.3.19. Meidixin (Tianjin) Co. Ltd
  • 13.3.20. Sunways India Pvt Ltd.
  • 13.3.21. Espansione Group
  • 13.3.22. Essilor Ltd
  • 13.3.23. SEODONG MEDICAL
  • 13.3.24. InMode Australia
  • 13.3.25. Novoxel

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations